Background: Extracorporeal photopheresis is a pheresis-based therapy that permits the
direct targeting of psoralen-mediated photochemotherapy to circulating pathogenic T cells …

Introduction Skin ulcers (SU) represent one of the most frequent manifestations of systemic
sclerosis (SSc), occurring in almost 50% of scleroderma patients. SSc-SU are often …

Photopheresis or extracorporeal photochemotherapy (ECP) is an immunomodulating
procedure that has been available for the treatment of cutaneous T‐cell lymphoma (CTCL) …

In the study, we investigated the influence of extracorporeal photochemotherapy (ECP) on
lymphocyte activation and cell death by determining CD95, Annexin V, CD69 and human …

ECP is a promising treatment approach in SS. Its effects in-vivo still remain unclear. We
investigated the expression of cytokines affecting T-cell proliferation prior to and during ECP …

Extracorporeal phototherapy (ECP) is a therapeutic approach based on the biological effect
of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA) on mononuclear cells …

Extracorporeal photochemotherapy is an immunomodulatory treatment wich is carried out in
three steps: first leukapheresis, then ex vivo PUVA treatment and finally autologous …

Four patients with chronic refractory plaque-type psoriasis without arthropathy were treated
with extracorporeal photopheresis every other week for 6 to 13 months. In patients 1 and 2 …

Abstract Background Recently, ultraviolet (UV) A1 phototherapy has been suggested as an
effective treatment for localized scleroderma (LS); however, the optimal dose of UVA1 still …

Background Extracorporeal photopheresis (ECP) is effective in conditions with opposing
immune etiology. ECP induces an immunomodulatory response through simultaneous …